Xiaojing Wang

5PUBLICATIONS
8CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)BiomaterialsNanophotonicsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2026
FGL2-HDAC11 Drives Immunothrombosis via NETs-Mediated Endothelial Capillarization in MASLD Fibrosis.

|Mar 03, 2026
Impairment of Rab7-dependent STING degradation hampers HBV replication but accelerates disease progression in chronic hepatitis B comorbid with MASLD.

Wenhui Wu, Qiang Gao, Suping Hai

|Jul 10, 2024
Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1α.

Suping Hai, Xitang Li, Erliang Xie

|Dec 18, 2021
High-fat-induced nonalcoholic fatty liver potentiates vulnerability to and the severity of viral hepatitis in a C3H/HeN mouse model.

Ting Wu, Junjian Hu, Xiaojing Wang

|May 28, 2019
Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice.

Xiaojing Wang, Lan Li, Hongwu Wang

Pageof 1

Frequent Collaborators

2 joint publications

Qin Ning

1 joint publications

Ting Wu

1 joint publications

Xiaoping Luo

1 joint publications

Hongwu Wang